﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/mankind-pharma-posts-q2-fy25-pat-up-30-at-rs-659-cr-16390</loc><lastmod>2024-11-06T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/venus-remedies-gets-approval-from-malaysian-pics-gmp-for-pre-filled-syringe-facility-16391</loc><lastmod>2024-11-06T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/dr-reddys-laboratories-posts-q2-fy25-pat-at-rs-12553-cr-16392</loc><lastmod>2024-11-06T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/pfizer-reports-q3-2024-revenue-higher-by-32-at-us-177-billion-16393</loc><lastmod>2024-11-06T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/granules-india-q2-fy25-pat-drops-5-yoy-to-rs-97-cr-16394</loc><lastmod>2024-11-06T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>